The CRB1 mutations in LCA patients have also been suggested to sensitise patients to keratoconus, a form of corneal dystrophy in which the cornea undergoes progressive thinning (McMahon et al., 2009). The gene discussed is CRB1; the disease is corneal dystrophy.